The question revolves around the ICH Harmonized Tripartite Guidelines, which are crucial in the pharmaceutical field, particularly concerning the stability testing of new drug substances and products. Let's examine the options to determine the correct guideline:
Given these explanations, the guideline that directly relates to the general requirements for the stability testing of new drug substances and products is Q1A (R2). It covers the comprehensive scope needed to ensure the adequacy of stability testing across various conditions. Therefore, the correct answer is:
Q1A (R2)
As per the Pharmacy Act, in the composition of Pharmacy Council of India, the total number of Ex‐officio members is
List I | List II | ||
|---|---|---|---|
| A | \(\Omega^{-1}\) | I | Specific conductance |
| B | \(∧\) | II | Electrical conductance |
| C | k | III | Specific resistance |
| D | \(\rho\) | IV | Equivalent conductance |
List I | List II | ||
|---|---|---|---|
| A | Constant heat (q = 0) | I | Isothermal |
| B | Reversible process at constant temperature (dT = 0) | II | Isometric |
| C | Constant volume (dV = 0) | III | Adiabatic |
| D | Constant pressure (dP = 0) | IV | Isobar |